Study guide
21.1 Adolescent Health & Puberty
Arab Board Pediatrics Part 1 Written Examination ABHS
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current ABHS Pediatrics Part 1 Exam Facts 1.2 How to Use This Guide & Part 1 Study Strategy
2 Neonatal Care I
2.1 Delivery-Room Management & Neonatal Resuscitation 2.2 Prematurity & Complications of Prematurity 2.3 Neonatal Jaundice & Hyperbilirubinemia
3 Neonatal Care II
3.1 Neonatal Sepsis & Infections 3.2 Neonatal Hypoglycemia & Metabolic Problems 3.3 Common Newborn Problems, Birth Injury & Screening
4 Infectious Diseases
4.1 Fever Without a Source & Sepsis Evaluation 4.2 Viral Exanthems & Common Childhood Infections 4.3 TORCH & Congenital Infections 4.4 Tuberculosis & Chronic/Unusual Pediatric Infections
5 Immunization
5.1 Routine Immunization Schedule & Vaccine Science 5.2 Contraindications, Adverse Events & Special Populations
6 Allergy & Immunology
6.1 Primary Immunodeficiency 6.2 Allergic Disease & Atopy
7 Growth & Development
7.1 Developmental Milestones & Red Flags 7.2 Growth Assessment & Failure to Thrive 7.3 Corrected Age & Preterm Follow-Up 7.4 Developmental & Behavioral Disorders
8 Nutrition
8.1 Breastfeeding & Infant Feeding 8.2 Weaning & Malnutrition 8.3 Micronutrient Deficiencies (Rickets, Iron Deficiency)
9 Pediatric Emergencies I
9.1 Pediatric Basic & Advanced Life Support 9.2 Anaphylaxis & Allergic Emergencies 9.3 Poisoning & Toxicology
10 Pediatric Emergencies II
10.1 Septic Shock & the Critically Ill Child 10.2 Upper Airway Emergencies (Epiglottitis, Foreign Body) 10.3 Non-Accidental Injury & Safeguarding
11 Cardiology
11.1 Cyanotic Congenital Heart Disease 11.2 Acyanotic Congenital Heart Disease & Heart Failure 11.3 Innocent Murmurs & Cardiac Evaluation 11.4 Rheumatic Fever & Acquired Heart Disease
12 Respiratory
12.1 Asthma 12.2 Bronchiolitis & Croup 12.3 Foreign Body Aspiration & Other Airway Disorders
13 Gastroenterology
13.1 Pyloric Stenosis & Vomiting Disorders 13.2 Intussusception & the Surgical Abdomen 13.3 Celiac Disease & Malabsorption 13.4 Hirschsprung Disease & Biliary Atresia
14 Nephrology & Genitourinary
14.1 Nephrotic Syndrome 14.2 Glomerulonephritis & Hematuria 14.3 UTI, Enuresis & Genitourinary Anomalies
15 Hematology & Oncology
15.1 Pediatric Anemias (Iron Deficiency, Thalassemia) 15.2 Sickle Cell Disease 15.3 Leukemia & Childhood Malignancies (incl. Wilms Tumor) 15.4 Bleeding & Platelet Disorders (ITP) & G6PD Deficiency
16 Endocrinology
16.1 Diabetes Mellitus & Diabetic Ketoacidosis 16.2 Thyroid & Adrenal Disorders 16.3 Growth Disorders & Puberty
17 Neurology
17.1 Febrile Seizures 17.2 Epilepsy Syndromes & Status Epilepticus 17.3 Bacterial Meningitis & CNS Infections 17.4 Neuromuscular Disorders & Headache
18 Genetics, Dysmorphology & Metabolism
18.1 Chromosomal Disorders & Dysmorphology 18.2 Inheritance Patterns, Consanguinity & Inborn Errors of Metabolism
19 Fluids, Electrolytes & Pharmacology
19.1 Maintenance Fluids & Dehydration 19.2 Electrolyte Disturbances 19.3 Pediatric Pharmacology & Prescribing/Dosing
20 Dermatology, ENT, Ophthalmology & Musculoskeletal
20.1 Common Pediatric Dermatology 20.2 ENT Disorders 20.3 Ophthalmology (Strabismus, Red Eye, Leukocoria) 20.4 Musculoskeletal & Rheumatologic Disorders
21 Adolescent Medicine & Ethics
21.1 Adolescent Health & Puberty 21.2 Ethics, Consent & Professionalism in Pediatrics
22 Final Review & Exam Strategy
22.1 High-Yield Numbers, Mnemonics & Cross-Topic Review 22.2 Exam-Day Strategy & Time Management
21.1 Adolescent Health & Puberty
Key Takeaways Explain This Topic AI
Testicular enlargement to a volume of 4 mL or more (Tanner stage 2) is the first physical sign of male puberty; breast budding (Tanner stage 2) is the first physical sign of female puberty.
Precocious puberty is onset of secondary sexual characteristics before age 8 in girls or age 9 in boys; delayed puberty is absent breast development by age 13 in girls, absent menarche by age 15-16, or absent testicular enlargement by age 14 in boys.
The HEADSSS interview moves deliberately from least to most sensitive domains (Home through Suicide/Safety) and should be conducted with the adolescent alone after confidentiality limits are explained.
Eating-disorder red flags include a falling growth-curve percentile, amenorrhea in a previously menstruating girl, orthostatic vital-sign changes, lanugo hair, and dental enamel erosion from self-induced vomiting.
Confidential one-on-one time improves adolescents' disclosure of sensitive issues, but safety, abuse, and suicidal risk override confidentiality.
Last updated: July 2026
Sexual Maturity Rating: Tanner Staging
Adolescent physical development is graded using the Tanner staging system (Sexual Maturity Rating, SMR), which describes five sequential stages (I-V) for genital or breast development and for pubic hair growth. On a best-of-five written paper, examiners frequently give a brief physical description and ask the candidate to identify the correct stage, so the defining feature of each stage — not just the stage number — must be memorized.
Male Genital Development
Stage 1 : Prepubertal; testicular volume under 4 mL, with testes, scrotum, and penis proportioned as in early childhood.
Stage 2 : Testicular and scrotal enlargement (testicular volume 4 mL or more) with reddening and a texture change of the scrotal skin; penis size is essentially unchanged. This is the first clinical sign of male puberty.
Stage 3 : The penis lengthens, with further testicular and scrotal growth.
Stage 4 : The penis increases further in length and breadth with development of the glans; scrotal skin darkens further.
Stage 5 : Adult genital size and shape.
Female Breast Development
Stage 1 : Prepubertal, with only nipple elevation.
Stage 2 : Breast budding — the first clinical sign of female puberty — with elevation of the breast and papilla as a small mound and enlargement of the areolar diameter.
Stage 3 : Further enlargement of breast and areola without separation of their contours.
Stage 4 : The areola and papilla project to form a secondary mound above the level of the breast.
Stage 5 : Mature breast; the areola recesses to the general contour of the breast while the papilla continues to project.
Pubic Hair (Both Sexes)
Stage 1 : No pubic hair (vellus only, similar to the abdomen).
Stage 2 : Sparse, fine, lightly pigmented, downy hair.
Stage 3 : Darker, coarser, curlier hair spreading sparsely over the pubis.
Stage 4 : Adult-type hair in quality, but not yet spread to the medial thighs.
Stage 5 : Adult quantity and distribution, spreading to the medial thighs.
Exam trap : genital/breast stage and pubic-hair stage are graded and reported on separate axes — a child can be genital stage 3 but pubic-hair stage 2 (for example, in some forms of precocious puberty driven by isolated adrenarche rather than true central puberty). Always answer for the specific axis the question stem asks about.
Normal Puberty Timing, and Precocious vs. Delayed Puberty
Puberty is triggered by reactivation of the hypothalamic-pituitary-gonadal (HPG) axis after a period of childhood quiescence. On average, girls begin puberty (thelarche) around 8-13 years , with menarche following roughly two to two-and-a-half years later (average approximately 12-13 years); boys begin puberty (testicular enlargement) around 9-14 years , typically one to two years later than girls on average.
Precocious puberty : onset of secondary sexual characteristics before age 8 in girls or age 9 in boys .
Delayed puberty : absence of breast development by age 13 in girls, absence of menarche by age 15-16 , or absence of testicular enlargement by age 14 in boys.
The detailed endocrine work-up for abnormal timing — bone-age radiographs, basal and GnRH-stimulated LH/FSH, and distinguishing central (gonadotropin-dependent) from peripheral (gonadotropin-independent) causes — is covered in the endocrinology chapter of this guide. For this chapter, the exam-relevant skill is recognizing when Tanner staging is abnormal for chronological age and knowing that abnormal timing triggers referral rather than reassurance.
The HEADSSS Psychosocial Interview
The HEADSSS interview (also written HEEADSSS when Eating is expanded as its own letter) is the structured framework for the adolescent psychosocial history, used at every well-adolescent visit:
- Letter Domain Sample focus
- H Home Household composition, relationships, conflict, safety at home
- E Education/Employment School performance, attendance, bullying, work
- E Eating Body image, dieting behavior, weight concerns
- A Activities/peer relationships Hobbies, friend group, social media use
- D Drugs Tobacco, alcohol, vaping, recreational drug use
- S Sexuality Orientation, activity, contraception, STI risk
- S Suicide/depression Mood, self-harm, suicidal ideation
- S Safety Injury, violence, abuse, access to weapons
Questions progress deliberately from least to most sensitive (Home toward Safety/Suicide/Sexuality), a sequence designed to build rapport before probing threatening topics. The interview should be conducted with the adolescent alone, without the parent present , after the clinician has explained the limits of confidentiality (developed further in the ethics section of this chapter).
Menstruation, Gynecomastia, and Mental Health Screening
Menstrual health topics appear frequently in adolescent vignettes:
Primary amenorrhea : no menarche by age 15 with otherwise normal pubertal development, or no menarche within 3 years of thelarche.
Primary dysmenorrhea : crampy pain with ovulatory cycles, typically beginning 6-12 months after menarche; NSAIDs are first-line. Progressive or severe pain should prompt evaluation for secondary causes such as endometriosis or müllerian anomalies.
Irregular cycles in the first 1-2 years after menarche are often physiologic (anovulatory) and do not require work-up unless accompanied by heavy bleeding, prolonged amenorrhea, or signs of hyperandrogenism.
Gynecomastia (palpable breast tissue in boys) is physiologic in up to 60% of pubertal boys — typically bilateral, tender, and under 4 cm in diameter, resolving spontaneously within 1-2 years. Red flags warranting further evaluation include unilateral enlargement, rapid growth, a fixed hard mass, or persistence beyond mid-puberty, to exclude medication effects, hyperthyroidism, testicular tumor, or Klinefelter syndrome (detailed work-up is covered in the endocrinology chapter).
Structured screening tools complement the HEADSSS domains:
PHQ-A (Patient Health Questionnaire modified for Adolescents) screens for depression.
CRAFFT screens for substance use (Car, Relax, Alone, Forget, Friends, Trouble).
Any disclosure of suicidal plan or intent requires immediate risk assessment and safety intervention; confidentiality is overridden to protect life.
Common Adolescent Health Issues: Eating Disorders and Confidentiality
Eating disorder red flags the exam expects a candidate to recognize include: a fall-off in growth-curve percentile (weight or BMI crossing down through percentile lines), amenorrhea in a previously menstruating girl, orthostatic hypotension or bradycardia, lanugo hair, dental enamel erosion (suggestive of self-induced vomiting), calluses on the dorsum of the hand (Russell sign), preoccupation with body image or weight despite a normal or low weight, and compulsive or excessive exercise. The brief SCOFF questionnaire (Sick, Control, One stone, Fat, Food) is a validated screening tool referenced in the adolescent-medicine literature and can appear as a distractor or correct answer in screening-tool questions.
Confidentiality is central to effective adolescent care: adolescents who believe their disclosures will automatically be shared with parents are less likely to seek care for sensitive issues (mental health, sexuality, substance use) and less likely to disclose honestly when they do present. Best practice is to see the adolescent for part of every visit without the parent present , to explicitly state what will and will not remain confidential before asking the sensitive questions, and to apply those limits consistently — safety, suspected abuse, and suicidal risk override confidentiality, as detailed in the companion ethics section of this chapter.